Klinikum Memmingen
About Klinikum Memmingen
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Abbott Medical Devices
3
AGO Research GmbH
1
Aesculap AG
1
Boehringer Ingelheim
1
Coloplast A/S
1
Daiichi Sankyo, Inc.
1
ETOP IBCSG Partners Foundation
1
EndoStim Inc.
1
Heinrich-Heine University, Duesseldorf
1
LivaNova
1
Medical University Innsbruck
1
Clinical Trials at Klinikum Memmingen
During the past decade, Klinikum Memmingen conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer
2004-01-01
Unknown status
1,234
Avoid FFS - Use of the Atrial Pacemaker Lead 1699 With Very Short Tip Ring Spacing to Avoid Far Field Sensing
2006-12-01
2008-08-01
Completed
204
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
2007-08-01
2019-05-15
Completed
4,884
Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease
2004-07-01
2007-01-01
Completed
400
Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapies in Primary Prevention Patients
2009-08-01
2013-01-01
Completed
543
GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
2012-08-22
2019-12-13
Completed
10,471
Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (ICDs) With Enhanced SVT Discriminators
2013-08-01
2016-10-01
Completed
735
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Memmingen" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "AGO Research GmbH" with 1 trials
sponsored, "Aesculap AG" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Coloplast A/S"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Memmingen"
#1 collaborator was "Aesculap, Inc." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Klinikum Memmingen
According to Clinical.Site data, the most researched conditions in "Klinikum Memmingen" are
"Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials), "Appendicitis" (1 trials), "Brady Tachy Syndrome" (1 trials) and "Bradycardia" (1 trials). Many other conditions were trialed in "Klinikum Memmingen" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Memmingen
Most popular intervention types in "Klinikum Memmingen" are "Device" (7 trials), "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "ACE inhibitor, angiotensin receptor blocker" (1 trials), "Altis Single Incision Sling" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Memmingen
The vast majority of trials in "Klinikum Memmingen" are
9 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Klinikum Memmingen
Currently, there are NaN active trials in "Klinikum Memmingen".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Klinikum Memmingen,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Memmingen, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 3 trials that are defined as “Not Applicable".